ESSENTIAL HYPERTENSION

โœ“ Medically ReviewedCARDIOVASCULARID: MDBTH003ICD-11: BA00๐Ÿšจ CRITICAL PROTOCOL
๐Ÿ’ก Core Clinical Guidance

Essential hypertension is a sustained elevation of systemic arterial blood pressure above 130/80 mmHg (ACC/AHA 2017) or 140/90 mmHg (ESC/ESH 2018) in the absence of an identifiable secondary cause. It is a major modifiable risk factor for cardiovascular disease, stroke, heart failure, and chronic kidney disease.

๐Ÿ“–

Definition

CLINICAL DEFINITION & PATHOPHYSIOLOGY

Essential hypertension is a sustained elevation of systemic arterial blood pressure above 130/80 mmHg (ACC/AHA 2017) or 140/90 mmHg (ESC/ESH 2018) in the absence of an identifiable secondary cause. It is a major modifiable risk factor for cardiovascular disease, stroke, heart failure, and chronic kidney disease.

๐Ÿ’Š

Pharmacological Management โ˜…

FIRST-LINE REGIMENS
5โ€“10 mgPOOnce dailyLong-term

Calcium channel blocker (CCB); preferred in older adults and Black patients

๐Ÿ’Š Ramipril

PREFERRED
2.5โ€“10 mgPOOnce dailyLong-term

ACE inhibitor; first-line in diabetic nephropathy, heart failure, post-MI

๐Ÿ’Š Losartan

50โ€“100 mgPOOnce dailyLong-term

ARB; alternative to ACEi if ACE inhibitor cough occurs

ALTERNATIVE & ESCALATION REGIMENS

๐Ÿ’Š Indapamide

1.5โ€“2.5 mgPOOnce dailyLong-term

Thiazide-like diuretic; preferred in Black patients when ACEi/ARB less effective

2.5โ€“10 mgPOOnce dailyLong-term

Beta-blocker; useful in heart failure, AF, post-MI; not first-line for uncomplicated HTN

ADJUNCTIVE & ADD-ON THERAPIES

๐Ÿ’Š Step 2: Add CCB or thiazide diuretic to ACEi/ARB

๐Ÿ’Š Step 3: Triple therapy (ACEi/ARB + CCB + thiazide diuretic)

๐Ÿ’Š Step 4 (resistant HTN): Add spironolactone 25 mg or alpha-blocker or beta-blocker

๐Ÿ’Š Consider statin in patients with 10-year CVD risk >10%

๐Ÿ’Š Aspirin only if established CVD (not for primary prevention)

SPECIAL PATIENT POPULATIONS
PREGNANCY
  • Labetalol (first-line)
  • Nifedipine (modified release)
  • Methyldopa
  • Avoid ACEi, ARBs, aldosterone antagonists
GERIATRICS
  • Target SBP <140 mmHg (or <150 in frail elderly)
  • Start low, go slow
  • Monitor for postural hypotension
PAEDIATRICS
  • ACE inhibitors or CCBs first-line
  • Investigate for secondary causes (renal disease, coarctation)
RENAL IMPAIRMENT
  • ACEi/ARBs are renoprotective but monitor eGFR and potassium
  • Avoid thiazides if eGFR <30
HEPATIC IMPAIRMENT
  • Use with caution; amlodipine may be preferred
CONTRAINDICATIONS & SAFETY CAUTIONS
  • ACE inhibitors/ARBs: avoid in pregnancy, bilateral renal artery stenosis, hyperkalaemia
  • Beta-blockers: avoid in asthma, bradycardia, second/third degree AV block
  • Thiazide diuretics: caution in gout (raise uric acid)
  • CCBs: amlodipine may worsen oedema; verapamil/diltiazem avoid in heart failure
โš–๏ธCLINICAL NOTICE & EDUCATIONAL DISCLAIMER

All content in Medobo is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional and local institutional protocols before administering medication or initiating treatment.